Identification of Novel Inhibitory Peptides of Protein-Protein Interactions Involved in DNA Repair as Potential Drugs in Breast Cancer Treatment
Abstract
Protein-protein interactions are critical to almost every cellular process. Disruption of these interactions would effectively interfere with the cell's functions and its ability to grow and divide normally. The Rad51 and Rad52 proteins are important proteins involved in DNA repair. Rad51 acts as a hexamer binding single-stranded DNA to drive strand exchange during homologous recombination. By blocking Rad51 from multimerization we can theoretically disrupt homologous recombination, and thus decrease the efficacy of DNA repair. Deficiency in DNA damage repair will sensitize cells to DNA damaging agents and thus such tumors can be effectively treated with a lower dose of chemotherapeutic agents/radiation. Short peptides of a few amino acids (5-10) have been shown to be enough to destabilize protein-protein interactions. Thus a library of random combinatorial peptides of sufficient complexity will in theory have an inhibitory molecule for any protein-protein interaction. This project attempts to isolate peptides that inhibit Rad 51 from multimerisation to be used as a chemosensitizing agent during chemo/radiotherapy using a modified Yeast two hybrid screen called the reverse two-hybrid system.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2001
- Accession Number
- ADA398548
Entities
People
- William T. Beck
Organizations
- University of Illinois at Chicago